CD146‐targeted nuclear medicine imaging in cancer: State of the art
VIEW · 2023-10 · 4 (5)
DOI: 10.1002/viw.20220085 ↗Kurz gefasst
Fachartikel in der Zeitschrift VIEW, 2023-03. Verfasst von Qi Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China.
Abstract (Originalsprache)
The transmembrane glycoprotein adhesion molecule CD146 is overexpressed in a wide variety of cancers. CD146 expression constitutes a marker of poor prognosis and correlates with cancer progression. Through molecular imaging, a specific biomarker's expression and distribution can be viewed in vivo non‐invasively. Radionuclide‐labeled monoclonal antibodies or relevant fragments that target CD146 may find potential applications in cancer imaging, thereby offering tremendous value in cancer diagnosis, staging, prognosis evaluation, and prediction of drug resistance. This review discusses the recent developments of CD146‐targeted molecular imaging via nuclear medicine, especially in malignant melanoma, brain tumor, lung cancer, liver cancer, breast cancer, and pancreatic cancer. Many studies have proved that CD146 targeting may present a promising strategy for cancer theranostics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
- Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States of America.
- Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing 100050, China.
Förderung
- NCI NIH HHS
- National Natural Science Foundation of China
Zitieren
APA
Yang, Q., Huang, W., Hsu, J. C., Song, L., Sun, X., Li, C., Cai, W., & Kang, L. (2023). CD146‐targeted nuclear medicine imaging in cancer: State of the art. VIEW, 4(5). https://doi.org/10.1002/viw.20220085
Vancouver
Yang Q, Huang W, Hsu JC, Song L, Sun X, Li C, et al. CD146‐targeted nuclear medicine imaging in cancer: State of the art. VIEW. 2023;4(5). doi:10.1002/viw.20220085
BibTeX
@article{Yang2023,
author = {Yang, Qi and Huang, Wenpeng and Hsu, Jessica C and Song, Lele and Sun, Xinyao and Li, Cuicui and Cai, Weibo and Kang, Lei},
title = {CD146‐targeted nuclear medicine imaging in cancer: State of the art},
journal = {VIEW},
year = {2023},
volume = {4},
number = {5},
doi = {10.1002/viw.20220085}
}
EUVIMED